Home LiteratureArticle Details
PMID: 4202457 Published · ppublish English Journal Article

Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.

British journal of cancer ·Vol. 28 ·No. 4 ·1973-10-00 ·Pages 293-8

Flannery GR, Chalmers PJ, Rolland JM, Nairn RC

Abstract

The development of serum factors by Wistar rats during the growth of a syngeneic squamous cell carcinoma has been investigated to clarify the nature of the local lymphocyte anergy reported previously in this system. Sera from tumour bearing animals were tested for cytotoxicity against tumour cells by in vitro microassay, and their ability to inhibit cell mediated cytotoxicity was also studied. Serum cytotoxicity was first detected after 2 weeks of tumour growth, reaching a peak at 4 weeks and then declining. Inhibitory activity was found only in the sera of animals with advanced tumours. Anti-tumour antibody either in the sera or bound to tumour cells was not detected by immunofluorescence techniques. No evidence of general immunological debilitation was found, the animals showing normal immune responses to sheep erythrocytes and killed Brucella abortus organisms throughout tumour growth. Serum inhibitory factors may be responsible for the decline in anti-tumour immunoreactivity and the local lymphocyte anergy observed in tumour bearing hosts.

MeSH Terms
Animals Antibodies, Bacterial Antibodies, Neoplasm Antibody Formation Antigens Brucella abortus/immunology Carcinoma, Squamous Cell/immunology,physiopathology Cytotoxicity Tests, Immunologic Erythrocytes/immunology Fluorescent Antibody Technique Hypersensitivity Immune Sera Immunity Lymphocytes/immunology Membranes/immunology Neoplasms, Experimental/immunology Rats Sheep/immunology
Chemicals
Antibodies, Bacterial Antibodies, Neoplasm Antigens Immune Sera
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Flannery G R
Chalmers P J
Rolland J M
Nairn R C
References (20)
20 references, click to expand
  1. Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth.
    J Natl Cancer Inst. 1969 Oct;43(4):843-56 PMID: 5344181
  2. Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.
    Int J Cancer. 1969 Sep 15;4(5):587-600 PMID: 5349009
  3. Prospects for immunotherapy of cancer: experience in experimental systems.
    Br Med J. 1970 Nov 21;4(5733):484-6 PMID: 5481224
  4. Immunological enhancement as studied by cell culture techniques.
    Annu Rev Microbiol. 1970;24:373-98 PMID: 4927135
  5. Partial mechanization of membrane immunofluorescent staining techniques.
    Clin Exp Immunol. 1971 May;8(5):835-8 PMID: 4931859
  6. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Int J Cancer. 1971 Mar 15;7(2):226-37 PMID: 5104167
  7. Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats.
    Cancer Res. 1971 Jun;31(6):890-900 PMID: 4326040
  8. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Cancer Res. 1971 Jul;31(7):997-1003 PMID: 4327089
  9. Cellular immunity and blocking antibodies to tumors.
    J Reticuloendothel Soc. 1971 Jul;10(1):131-6 PMID: 5121177
  10. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
    Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5 PMID: 5288389
  11. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    J Natl Cancer Inst. 1970 Sep;45(3):443-53 PMID: 5523193
  12. Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence.
    Transplant Rev. 1969;1:92-113 PMID: 4945477
  13. Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates.
    Int J Cancer. 1972 Jan 15;9(1):242-7 PMID: 5020937
  14. Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.
    Int J Cancer. 1972 Mar 15;9(2):274-83 PMID: 4504846
  15. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.
    Br J Cancer. 1972 Jun;26(3):164-73 PMID: 5047140
  16. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Nat New Biol. 1972 Aug 9;238(84):185-6 PMID: 4340574
  17. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cancer Res. 1972 Nov;32(11):2421-6 PMID: 5082590
  18. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Br J Cancer. 1972 Dec;26(6):427-38 PMID: 4119105
  19. Serum immunoglobulins and antibodies in congenitally athymic (nude) mice.
    Aust J Exp Biol Med Sci. 1972 Oct;50(5):625-35 PMID: 4631222
  20. Immune response to a syngeneic rat tumour: development of regional node lymphocyte anergy.
    Br J Cancer. 1973 Aug;28(2):118-22 PMID: 4542343
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
1973-10-00
Pages
293-8
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2008897
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]